What is the Return on Assets (ROA) of Sotac Pharmaceuticals this year?
The Return on Assets (ROA) of Sotac Pharmaceuticals is 0.08 undefined this year.
Sotac Pharmaceuticals ROA 2024
Sotac Pharmaceuticals ROA
0.08
Sotac Pharmaceuticals Dividend yield
Ticker
SOTAC.NS
ISIN
INE0O2D01012
In 2024, Sotac Pharmaceuticals's return on assets (ROA) was 0.08, a -219.78% increase from the -0.07 ROA in the previous year.
Sotac Pharmaceuticals Aktienanalyse
What does Sotac Pharmaceuticals do?
Sotac Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Sotac Pharmaceuticals's Return on Assets (ROA)
Sotac Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Sotac Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Sotac Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Sotac Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Sotac Pharmaceuticals Stock
What was the ROA of Sotac Pharmaceuticals compared to the previous year?
The ROA of Sotac Pharmaceuticals has increased by -219.78% compared to the previous year.
What consequences do high ROA have for investors of Sotac Pharmaceuticals?
A high ROA is advantageous for investors of Sotac Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Sotac Pharmaceuticals?
A low ROA can be unfavorable for investors of Sotac Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Sotac Pharmaceuticals affect the company?
An increase in ROA of Sotac Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Sotac Pharmaceuticals impact the company?
A reduction in the ROA of Sotac Pharmaceuticals can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Sotac Pharmaceuticals?
Some factors that can influence the ROA of Sotac Pharmaceuticals include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Sotac Pharmaceuticals important for investors?
The ROA of Sotac Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Sotac Pharmaceuticals take to improve ROA?
To improve ROA, Sotac Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Sotac Pharmaceuticals pay?
Over the past 12 months, Sotac Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sotac Pharmaceuticals is expected to pay a dividend of 0 INR.
What is the dividend yield of Sotac Pharmaceuticals?
The current dividend yield of Sotac Pharmaceuticals is .
When does Sotac Pharmaceuticals pay dividends?
Sotac Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sotac Pharmaceuticals?
Sotac Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Sotac Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sotac Pharmaceuticals located?
Sotac Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sotac Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sotac Pharmaceuticals from 6/6/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.
When did Sotac Pharmaceuticals pay the last dividend?
The last dividend was paid out on 6/6/2024.
What was the dividend of Sotac Pharmaceuticals in the year 2023?
In the year 2023, Sotac Pharmaceuticals distributed 0 INR as dividends.
In which currency does Sotac Pharmaceuticals pay out the dividend?
The dividends of Sotac Pharmaceuticals are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sotac Pharmaceuticals
Our stock analysis for Sotac Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sotac Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Sotac Pharmaceuticals Revenue
- Sotac Pharmaceuticals Net Income
- Sotac Pharmaceuticals P/E
- Sotac Pharmaceuticals P/S
- Sotac Pharmaceuticals EBIT
- Sotac Pharmaceuticals Dividend
- Sotac Pharmaceuticals Stocks
- Sotac Pharmaceuticals Market capitalization
- Sotac Pharmaceuticals Debt
- Sotac Pharmaceuticals Liabilities
- Sotac Pharmaceuticals Equity
- Sotac Pharmaceuticals AAQS
- Sotac Pharmaceuticals Employees
- Sotac Pharmaceuticals ROE
- Sotac Pharmaceuticals ROA
- Sotac Pharmaceuticals ROCE